Yellow Fever Clinical Trials Yellow Fever RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans
Condition:   Treatment of Acute Yellow Fever Virus Infection Interventions:   Biological: TY014;   Other: 0.9% Saline Sponsor:   Tysana Pte Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2018 Category: Research Source Type: clinical trials